Eprosartan Mesylate
CAS No. 144143-96-4
Eprosartan Mesylate( SKF 108566J )
Catalog No. M11872 CAS No. 144143-96-4
Eprosartan is a nonpeptide angiotensin II receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 38 | In Stock |
|
| 10MG | 38 | In Stock |
|
| 25MG | 60 | In Stock |
|
| 50MG | 72 | In Stock |
|
| 100MG | 104 | In Stock |
|
| 200MG | 161 | In Stock |
|
| 500MG | 272 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEprosartan Mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEprosartan is a nonpeptide angiotensin II receptor antagonist.
-
DescriptionEprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells.(In Vitro):Eprosartan (SKF-108566J) inhibits [125I]AII binding to human liver membranes (IC50 of 1.7 nM) and to rat mesenteric artery membranes (IC50 of 1.5 nM). In rabbit aortic smooth muscle cells, Eprosartan caused a concentration-dependent inhibition of AII-induced increases in intracellular Ca2+ levels.(In Vivo):In conscious normotensive rats, i.v. administration of Eprosartan (0.01-0.3 mg/kg) produced dose-dependent parallel shifts in the AII pressor dose-response curve. Administration of Eprosartan (3-10 mg/kg) intraduodenally or intragastrically to conscious normotensive rats resulted in a dose-dependent inhibition of the pressor response to AII (250 ng/kg, i.v.). At 10 mg/kg, i.d., significant inhibition of the pressor response to AII was observed for 3 hr.
-
In VitroEprosartan (SKF-108566J) inhibits [125I]AII binding to human liver membranes (IC50 of 1.7 nM) and to rat mesenteric artery membranes (IC50 of 1.5 nM). In rabbit aortic smooth muscle cells, Eprosartan caused a concentration-dependent inhibition of AII-induced increases in intracellular Ca2+ levels.
-
In VivoIn conscious normotensive rats, i.v. administration of Eprosartan (0.01-0.3 mg/kg) produced dose-dependent parallel shifts in the AII pressor dose-response curve. Administration of Eprosartan (3-10 mg/kg) intraduodenally or intragastrically to conscious normotensive rats resulted in a dose-dependent inhibition of the pressor response to AII (250 ng/kg, i.v.). At 10 mg/kg, i.d., significant inhibition of the pressor response to AII was observed for 3 hr.
-
SynonymsSKF 108566J
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorAT1 receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number144143-96-4
-
Formula Weight520.62
-
Molecular FormulaC23H24N2O4S·CH4O3S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 4 mg/mL (7.68 mM); DMSO: 104 mg/mL (199.76 mM)
-
SMILESCCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O.CS(=O)(=O)O
-
Chemical Name4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Plosker GL, et al. Drugs, 2000, 60(1), 177-20
molnova catalog
related products
-
Ramiprilat
Ramiprilat is an angiotensin-converting enzyme (ACE) inhibitor?with antihypertensive activity.
-
Breviscapin
Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.
-
Leucylarginylproline
Leucylarginylproline is an?inhibitor of angiotensin-converting enzyme (ACE) (IC50 : 0.27μM).
Cart
sales@molnova.com